Rein Therapeutics Inc. (RNTX) has a market capitalization of $45.7M and trades at $1.63. The 52-week range is 1.02-2.4.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.8, Earnings Per Share (EPS) of $-1.96.
The stock has a beta of 1.40, operates in the Healthcare sector.
